These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31693252)

  • 1. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J; Lv J; Chen J; Zhang X; Ji Y
    Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
    Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
    Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
    Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
    Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
    Zhang L; Liu Z; Dong Y; Kong L
    Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
    Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer.
    Qiu S; Qiu Y; Deng L; Nie L; Ge L; Zheng X; Jin D; Jin K; Zhou X; Su X; Cai B; Li J; Tu X; Gong L; Liu L; Liu Z; Bao Y; Ai J; Lin T; Yang L; Wei Q
    Chin Med J (Engl); 2024 Jan; 137(2):209-221. PubMed ID: 37390491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
    Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.